Search research articles
Contact Us
Filters
Showing results (311-320 of 373) with videos related to
Page
of 38
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2020
Early Response to First-Line Anti-PD-1 Treatment in Hodgkin Lymphoma: A PET-Based Analysis from the Prospective, Randomized Phase II NIVAHL Trial
Conrad-Amadeus Voltin, Jasmin Mettler, Lutz van Heek, et al.
Journal of Lipid Research
|
October 3, 2020
Insulin resistance dysregulates CYP7B1 leading to oxysterol accumulation: a pathway for NAFL to NASH transition
Genta Kakiyama, Dalila Marques, Rebecca Martin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 26, 2015
In Patients With Cirrhosis, Driving Simulator Performance Is Associated With Real-life Driving
Mette M Lauridsen, Leroy R Thacker, Melanie B White, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 3, 2014
Cognitive reserve is a determinant of health-related quality of life in patients with cirrhosis, independent of covert hepatic encephalopathy and model for end-stage liver disease score
Ankit V Patel, James B Wade, Leroy R Thacker, et al.
Blood
|
May 31, 2023
Interim PET-guided treatment for early-stage NLPHL: a subgroup analysis of the randomized GHSG HD16 and HD17 studies
Dennis A Eichenauer, Ina Bühnen, Christian Baues, et al.
Digestive Diseases and Sciences
|
March 5, 2017
Symptom Domain Groups of the Patient-Reported Outcomes Measurement Information System Tools Independently Predict Hospitalizations and Re-hospitalizations in Cirrhosis
Kavish R Patidar, Leroy R Thacker, James B Wade, et al.
Hemasphere
|
August 20, 2025
Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients
Paul J Bröckelmann, Boris Böll, Daniel Molin, et al.
Journal of Hepatology
|
August 15, 2012
Asymmetric dimethylarginine is strongly associated with cognitive dysfunction and brain MR spectroscopic abnormalities in cirrhosis
Jasmohan S Bajaj, Vishwadeep Ahluwalia, James B Wade, et al.
Blood
|
April 2, 2026
Gonadal Function and Fertility after Hodgkin Lymphoma Treatment with Nivolumab-AVD in the Phase II GHSG NIVAHL Trial
Anne Sophie Robertz, Ina Bühnen, Julia Meissner, et al.
Hepatology (Baltimore, Md.)
|
May 1, 2019
Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial
Jasmohan S Bajaj, Nita H Salzman, Chathur Acharya, et al.
Page
of 38
Search research articles
Search
Showing results (311-320 of 373) with videos related to
Sort By:
Page
of 38
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2020
Early Response to First-Line Anti-PD-1 Treatment in Hodgkin Lymphoma: A PET-Based Analysis from the Prospective, Randomized Phase II NIVAHL Trial
Conrad-Amadeus Voltin, Jasmin Mettler, Lutz van Heek, et al.
Journal of Lipid Research
|
October 3, 2020
Insulin resistance dysregulates CYP7B1 leading to oxysterol accumulation: a pathway for NAFL to NASH transition
Genta Kakiyama, Dalila Marques, Rebecca Martin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 26, 2015
In Patients With Cirrhosis, Driving Simulator Performance Is Associated With Real-life Driving
Mette M Lauridsen, Leroy R Thacker, Melanie B White, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 3, 2014
Cognitive reserve is a determinant of health-related quality of life in patients with cirrhosis, independent of covert hepatic encephalopathy and model for end-stage liver disease score
Ankit V Patel, James B Wade, Leroy R Thacker, et al.
Blood
|
May 31, 2023
Interim PET-guided treatment for early-stage NLPHL: a subgroup analysis of the randomized GHSG HD16 and HD17 studies
Dennis A Eichenauer, Ina Bühnen, Christian Baues, et al.
Digestive Diseases and Sciences
|
March 5, 2017
Symptom Domain Groups of the Patient-Reported Outcomes Measurement Information System Tools Independently Predict Hospitalizations and Re-hospitalizations in Cirrhosis
Kavish R Patidar, Leroy R Thacker, James B Wade, et al.
Hemasphere
|
August 20, 2025
Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients
Paul J Bröckelmann, Boris Böll, Daniel Molin, et al.
Journal of Hepatology
|
August 15, 2012
Asymmetric dimethylarginine is strongly associated with cognitive dysfunction and brain MR spectroscopic abnormalities in cirrhosis
Jasmohan S Bajaj, Vishwadeep Ahluwalia, James B Wade, et al.
Blood
|
April 2, 2026
Gonadal Function and Fertility after Hodgkin Lymphoma Treatment with Nivolumab-AVD in the Phase II GHSG NIVAHL Trial
Anne Sophie Robertz, Ina Bühnen, Julia Meissner, et al.
Hepatology (Baltimore, Md.)
|
May 1, 2019
Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial
Jasmohan S Bajaj, Nita H Salzman, Chathur Acharya, et al.
Page
of 38